Video: Adrenergic Receptors: ɑ Subtype

JoVE Core

Pharmacology

A subscription to JoVE is required to view this content.

live

MEDIA_ELEMENT_ERROR: Format error

6.3 : Adrenergic Receptors: ɑ Subtype

ɑ-adrenoceptors show higher affinity to Adr and NA than ISO.

They are classified into ɑ₁ and ɑ₂ subtypes based on various factors.

Upon stimulation, ɑ₁ receptors activate phospholipase C , releasing IP₃ and DAG as secondary messengers.

They are present in the postsynaptic effector organs, particularly the smooth muscles of the cardiovascular and GI systems, and are responsible for vasoconstriction, increased blood pressure, and GI muscle relaxation.

ɑ₂ receptor stimulation inhibits adenylyl cyclase, decreases cAMP production, and modulates ion channels.

They are predominantly present in autonomic nerve terminals, pancreatic beta cells, vascular smooth muscles, and platelets. They affect the release of autonomic neurotransmitters and insulin, vascular smooth muscles contraction and platelet aggregation.

ɑ₁ and ɑ₂ receptors are subdivided into three subtypes based on subtype-selective drugs. For instance, tamsulosin—used for treating prostatic hyperplasia—preferentially inhibits ɑ₁-A receptors in the prostate gland over ɑ₁-B receptors in blood vessels, so they have fewer cardiovascular side effects.

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:

Adrenaline ≥ Noradrenaline >> Isoprenaline

α-adrenoceptors are further divided into α₁ and α₂-adrenoceptors.

α₁-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate (IP₃)—diacylglycerol (DAG) pathway.

α₂-Adrenoceptors: α₂-adrenoceptors are predominantly located on the presynaptic nerve endings, which control noradrenaline release. They are also found on presynaptic parasympathetic neurons. Noradrenaline released from a presynaptic sympathetic interacting with these receptors causes inhibition of ACh release. In contrast to α₁ receptors, activation of α₂ receptors causes inhibition of adenylyl cyclase, decreased intracellular cAMP levels, and closure of ion channels.

Further subdivisions: The α₁ and α₂ receptors are further classified into α_1A, α_1B, α_1D and α_2A, α_2B, α_2C subtypes, respectively, for a better understanding of drug-receptor selectivity.

Tags

Adrenergic Receptors Adrenoceptors Catecholamine Agonists adrenoceptors adrenoceptors Phospholipase C Inositol 1 4 5 trisphosphate Diacylglycerol Presynaptic Nerve Endings Noradrenaline Release Adenylyl Cyclase CAMP Levels Drug receptor Selectivity

From Chapter 6:

article

Now Playing

6.3 : Adrenergic Receptors: ɑ Subtype

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Views

article

6.1 : Adrenergic Neurons: Neurotransmission

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

3.1K Views

article

6.2 : Adrenergic Receptors (Adrenoceptors): Classification

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.0K Views

article

6.4 : Adrenergic Receptors: β Subtype

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.4K Views

article

6.5 : Adrenergic Agonists: Direct-Acting Agents

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.2K Views

article

6.6 : Adrenergic Agonists: Indirect-Acting Agents

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Views

article

6.7 : Adrenergic Agonists: Mixed-Action Agents

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

573 Views

article

6.8 : Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.4K Views

article

6.9 : Adrenergic Agonists: Therapeutic Classification

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

578 Views

article

6.10 : Adrenergic Agonists: Therapeutic Uses

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

645 Views

article

6.11 : Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

722 Views

article

6.12 : Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

474 Views

article

6.13 : Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

431 Views

article

6.14 : Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

446 Views

article

6.15 : Adrenergic Antagonists: ɑ and β-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

352 Views

See More

Copyright © 2025 MyJoVE Corporation. All rights reserved

We use cookies to enhance your experience on our website.

By continuing to use our website or clicking “Continue”, you are agreeing to accept our cookies.

Learn More